- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 25/00 - Drugs for disorders of the nervous system
Patent holdings for IPC class A61P 25/00
Total number of patents in this class: 17586
10-year publication summary
|
671
|
652
|
704
|
1006
|
1187
|
1268
|
1317
|
1383
|
1352
|
389
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| F. Hoffmann-La Roche AG | 7958 |
300 |
| Janssen Pharmaceutica N.V. | 3839 |
217 |
| Takeda Pharmaceutical Company Limited | 2961 |
182 |
| The Regents of the University of California | 18943 |
166 |
| Glaxo Group Limited | 4496 |
124 |
| Hoffmann-La Roche Inc. | 3060 |
124 |
| AstraZeneca AB | 3042 |
120 |
| Novartis AG | 11238 |
117 |
| H. Lundbeck A/S | 1252 |
107 |
| Neurosearch A/S | 222 |
101 |
| Pfizer Inc. | 3322 |
86 |
| sanofi-aventis | 427 |
86 |
| Daiichi Sankyo Company, Limited | 1829 |
82 |
| Centre National de La Recherche Scientifique | 9632 |
77 |
| The Johns Hopkins University | 5377 |
77 |
| Sage Therapeutics, Inc. | 312 |
77 |
| Bristol-myers Squibb Company | 5080 |
72 |
| Boehringer Ingelheim International GmbH | 4629 |
70 |
| Osaka University | 3143 |
63 |
| Vertex Pharmaceuticals Incorporated | 1581 |
61 |
| Other owners | 15277 |